MedTrace Logo

Multi-dose Ibuprofen Prophylaxis for IUD-insertion

NCT03868137 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2020-10-09

No results posted yet for this study

Summary

This study compares the effectiveness of decreasing pain at time of and day after intrauterine device (IUD) insertion when patients take three doses of Ibuprofen versus three doses of placebo.

Conditions

  • Pelvic Pain
  • IUD

Interventions

DRUG

Ibuprofen

3 doses of Ibuprofen 800 mg

DRUG

Placebos

Placebo

Sponsors & Collaborators

  • Orlando VA Medical Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-28
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03868137 on ClinicalTrials.gov